Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

921.9000 1.70 (0.18%)

NSE Sep 25, 2025 15:31 PM

29.30% Fall from 52W High

Volume: 65,174

Alembic Pharmaceuticals Ltd.

02 May 2025

921.90

0.18%

Company Update

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Alembic Pharmaceuticals Limited receives USFDA Final approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg.

More from Alembic Pharmaceuticals Ltd.

Recommended

Market closes lower, HAL bags Rs 66,500 cr order for fighter jets

Trendlyne Marketwatch | 25 Sep 2025, 03:57PM

Indices at a glance: Biggest winners and losers over the past year

The Baseline | 25 Sep 2025, 12:17PM

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals